Biohaven Craters By A Third On Migraine Drug Study Rivaling Allergan [Investor's Business Daily]
ALDER BIOPHARMACEUTICALS INC (ALDR)
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.alderbio.com/node/5806
Company Research
Source: Investors Business Daily
Related news 3/23/2018 Track the latest trends and leading stocks in the biotech and pharmaceutical industries. Will This Coming IPO Biotech Undercut Gilead, Novartis In Cancer Drugs? Powerhouse Duo Takes On Gilead, Allergan In Liver Disease, But Stocks Dip Biotech Stock Hit After CEO Suddenly Quits At Critical Juncture Trump Pledges Again To Cut Drug Prices — And Biotech Stocks Ignore Him Why Amgen Shouldn't Use Its War Chest For A Celgene Megamerger How The International Space Station Could Operate Commercially How A Strong Trial From Regeneron Pharma Could Help These Rivals How This Small-Cap Biotech Plans To Chip Away At Amgen's Biggest Drugs Biohaven Pharmaceuticals ( BHVN ) cratered by a third early Monday after it unveiled the results of two late-stage trials for its migraine drug, a competitor to an investigational therapy from Allergan ( AGN ). The drug, called rimegepant , was tested as a treatment for acute migraine. In two
Show less
Read more
Impact Snapshot
Event Time:
ALDR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALDR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALDR alerts
High impacting ALDER BIOPHARMACEUTICALS INC news events
Weekly update
A roundup of the hottest topics